Background: Numerous studies have confirmed the importance of advance care planning. Despite the benefits of directed end-of-life discussions, a variety of barriers including discomfort with the topic, physician ideology, lack of time and reimbursement, delaying discussions, and lack of training impede physicians from facilitating these crucial conversations with their patients. This study aims to understand physicians' perceptions to additional barriers to advance care planning with patients and their families.

Methods: Interviews with 19 practicing physicians (seven women and 12 men). Their perceptions were noted in interviews that were audiotaped, transcribed, and analyzed (n = 19).

Results: Physicians continue to face barriers to advance care planning as well as struggle with additional challenges such as difficulty with families, lack of patient education, inconsistencies and accessibility of advance directive documents, and lack of physician-physician communication or agreement in care. Further analysis reveals contradictions regarding physician comfort level and the role of primary care. These results reveal the complexity of providing medical care and the continued need for improvements in physician-patient communication about end-of-life care.

Conclusions: Complex challenges in communication impede the delivery of successful end-of-life experiences for patients and their families. With improvements in the practices of advance care planning, many of these challenges can be removed - enabling individuals to remain in control as they near the end of their lives and preventing unnecessary pain and suffering on behalf of the patient and family.

Download full-text PDF

Source

Publication Analysis

Top Keywords

advance care
20
care planning
20
barriers advance
12
care
8
advance
6
planning
5
physician perceptions
4
barriers
4
perceptions barriers
4
planning background
4

Similar Publications

Exploring the Credibility of Large Language Models for Mental Health Support: Protocol for a Scoping Review.

JMIR Res Protoc

January 2025

Data and Web Science Group, School of Business Informatics and Mathematics, University of Manneim, Mannheim, Germany.

Background: The rapid evolution of large language models (LLMs), such as Bidirectional Encoder Representations from Transformers (BERT; Google) and GPT (OpenAI), has introduced significant advancements in natural language processing. These models are increasingly integrated into various applications, including mental health support. However, the credibility of LLMs in providing reliable and explainable mental health information and support remains underexplored.

View Article and Find Full Text PDF

Background: Although substantial progress has been made in establishing evidence-based psychosocial clinical interventions and implementation strategies for mental health, translating research into practice-particularly in more accessible, community settings-has been slow.

Objective: This protocol outlines the renewal of the National Institute of Mental Health-funded University of Washington Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness Center, which draws from human-centered design (HCD) and implementation science to improve clinical interventions and implementation strategies. The Center's second round of funding (2023-2028) focuses on using the Discover, Design and Build, and Test (DDBT) framework to address 3 priority clinical intervention and implementation strategy mechanisms (ie, usability, engagement, and appropriateness), which we identified as challenges to implementation and scalability during the first iteration of the center.

View Article and Find Full Text PDF

Purpose: Mobocertinib is an oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that targets exon 20 insertion (ex20ins) mutations in non-small cell lung cancer (NSCLC). This open-label, phase III trial (EXCLAIM-2: ClinicalTrials.gov identifier: NCT04129502) compared mobocertinib versus platinum-based chemotherapy as first-line treatment of ex20ins+ advanced/metastatic NSCLC.

View Article and Find Full Text PDF

Data collected from scholars across twenty-three countries over the past decade (2010-2019) reveals a 40% decrease in financial support for medicinal chemistry projects. The decline is especially notable among projects focused on small organic molecules. This drop in grants indicates a troubling trend that could jeopardize future drug development by undermining research in this crucial field.

View Article and Find Full Text PDF

Foundation Models for Translational Cancer Biology.

Annu Rev Biomed Data Sci

January 2025

1Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, California, USA;

Cancer remains a leading cause of death globally. The complexity and diversity of cancer-related datasets across different specialties pose challenges in refining precision medicine for oncology. Foundation models offer a promising solution.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!